$KRRO

Aiyar Ram sold $63K of KRRO

Aiyar Ram (President and CEO) sold 5,802 shares of Korro Bio, Inc. (KRRO) at $10.84 on 2026-08-04.

Original reporting
SEC EDGAR · Aiyar Ram
Published Aug 5, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 6:26 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$KRRO
Neutral
medium confidence
Mentioned
$KRRO
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KRRONeutralLow
01

Why it matters

Insider selling can influence short-term sentiment, especially when no 10b5-1 plan is cited, but it does not change fundamentals absent accompanying operational or financial disclosures.

02

Market read

Traders may note the insider sale for sentiment monitoring, but there is no new guidance, trial, or deal information here.

03

What to watch

The filing does not state reasons for the sale, and the disclosed transaction value is modest; without follow-on buys/sells or performance news, trading impact is likely limited.

Relevance 3/10Novelty 3/10Timing: filed 2026-08-05, transaction dated 2026-08-04

Background

The article is a SEC Form 4 insider transaction disclosure for Korro Bio, Inc.

Company-level read

Ticker impact

$KRRONeutralMedium confidence
Context

Korro Bio CEO Aiyar Ram filed a Form 4 selling 5,802 shares at $10.8440 on 2026-08-04, totaling about $62.9K.

Expected impact

Likely limited near-term price impact; any effect would be sentiment-driven and small.

Evidence & confidence

Form 4 insider sales are common and the disclosed size ($62.9K) is relatively small versus typical market moves. The absence of a stated 10b5-1 plan may raise attention, but the filing does not provide new company performance or guidance.

Market effects

No sector-level signal; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity management (taxes, diversification) and does not necessarily reflect negative expectations.

Key entities

  • Korro Bio, Inc.

    Subject of the Form 4 insider sale by its CEO.

  • Aiyar Ram

    President and CEO who sold 5,802 shares at $10.8440.

Related articles

$KRROMed

Korro Bio, Inc. (KRRO): Results of Operations and Financial Condition

Korro Bio, Inc. (KRRO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 4 krro-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Korro Reports Second Quarter 2026 Financial Results and Provides Corporate Update — KRRO-121, a potential first-in-class transformational treatment for hyperammonemia, remains on track to commence first-in-human clinical tria